Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Pablo A Gaspar

Has grant

Profesor Asociado

Universidad de Chile

No Info

Research Interests

Explore related searches

Professors in Neuropsychology

Recent Grants

Grant: Close

Núcleo Milenio para Mejorar la Salud Mental de Adolescentes y Jóvenes, Imhay [Millennium Nucleus to Improve the Mental Health of Adolescents and Youths, Imhay]

Open Date: 2021-12-01

Close Date: 2024-12-01

Grant: Close

Hyperandrogenism during prenatal and pubertal development alters functional brain networks compromising social cognition in daughters of women with Polycystic Ovary Syndrome: a double hit hypothesis

Open Date: 2021-01-01

Close Date: 2025-01-01

Grant: Close

Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT)

Open Date: 2020-09-08

Close Date: 2026-05-31

Grant: Close

Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium

Open Date: 2020-09-01

Close Date: 2025-06-01

Grant: Close

Neuronal dynamic underlying the emergence of chronic psychosis from the psychosis-risk syndromes

Open Date: 2014-11-01

Close Date: 2017-11-01

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (20)

Isabelle Scott

University of Melbourne

AUSTRALIA

Pablo A Gaspar

Research Interests

Explore related searches

Recent Grants

Articles (16)

Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program

The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program

The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures

Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program

Clinical prediction model for transition to psychosis in individuals meeting At Risk Mental State criteria

Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program

Automatic Speech Recognition in Psychiatric Interviews: A Rocket to Diagnostic Support in Psychosis

Lifetime prevalence of psychotic-like experiences and associated factors in Chile

Women with polycystic ovary syndrome (PCOS): Likelihood of cooccurring neuropsychiatric conditions and the dual hit hypothesis

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

Fixational eye movements and their associated evoked potentials during natural vision are altered in schizophrenia

Automatic Speech Recognition in Psychiatric Interviews: A Rocket to Diagnostic Support in Psychosis,Reconocimiento automático del habla en entrevistas psiquiátricas: un impulso al soporte diagnóstico en psicosis

Disrupted third visual pathway function in schizophrenia: Evidence from real and implied motion processing

Imitative inhibitory control is associated with psychotic experiences in a sample from the general population

Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive impairment in early stages of psychosis

Collaborators (20)

Isabelle Scott

Scott Woods

Sylvain Bouix

Louise Birkedal Glenthøj

Cheryl Corcoran

Tina Gupta

Kristina Ballestad Gundersen

Leslie Horton

Kelly Allott

Holly Hamilton

Andrés Estradé

Paris Alexandros Lalousis

Rachel Upthegrove

Juan José Mariman

Michael Harms

Christy LM Hui

Sophie Parker

VIJAY MITTAL

Peter J. Uhlhaas

Laura Bonnett

Make your next move.